News ArticleApollo Hospitals Enterprise Completes ₹9,500 Million Divestment, Gains 9.9% Equity Stake in Kids Clinic India
Transaction closure on 3 November 2026 transfers ownership of Specialty and Fertility Units to Kids Clinic India Limited
Apollo Hospitals Enterprise Limited announced completion of the divestment by its subsidiary Apollo Health and Lifestyle Limited of its entire shareholding in Apollo Specialty Hospitals Pvt Ltd and Apollo Fertility Centre Pvt Ltd to Kids Clinic India Limited, receiving cash consideration of ₹7,650 million plus a 9.9% equity stake valued at ₹1,850 million in Kids Clinic. The deal closed on 3 November 2026.
Apollo Hospitals Enterprise Limited
General / Other
Apollo Hospitals Enterprise Limited has completed the divestment by its wholly owned subsidiary, Apollo Health and Lifestyle Limited, of its entire shareholding in Apollo Specialty Hospitals Pvt Ltd and Apollo Fertility Centre Pvt Ltd to Kids Clinic India Limited. The closing of the transaction occurred on 3 November 2026.
The transaction was conducted at an enterprise value of approximately ₹9,500 million, which includes a cash consideration of ₹7,650 million plus an effective equity stake of approximately 9.9% in Kids Clinic India Limited (KCIL) valued at ₹1,850 million.
With the completion, Apollo Specialty Hospitals Pvt Ltd and Apollo Fertility Centre Pvt Ltd ceased to be subsidiaries of Apollo Health and Lifestyle Limited.
In addition to this transaction, the Board of Apollo Hospitals approved unaudited standalone and consolidated financial results for the three and six months ended 30 September 2026, along with management personnel changes including the cessation of Dr. Madhu Sasidhar as President & CEO - Hospitals Division from 14 November 2026.
Apollo Hospitals also announced appointments of new senior management personnel including Dr. Ritu Garg as Chief Executive Officer, Multi Regions, among others.
Highlights
- Divestment closed on 3 November 2026 with Kids Clinic India Limited.
- Enterprise value of the deal approximately ₹9,500 million.
- Apollo Health and Lifestyle Limited received ₹7,650 million in cash and a 9.9% equity stake in Kids Clinic India valued at ₹1,850 million.
- Apollo Specialty Hospitals Pvt Ltd and Apollo Fertility Centre Pvt Ltd are no longer subsidiaries of Apollo Health and Lifestyle Limited.
- Dr. Madhu Sasidhar will cease to be President & CEO - Hospitals Division effective 14 November 2026.
- New senior management appointments made including Dr. Ritu Garg as CEO for Multi Regions.
Key Data Snapshot
What happened
- Apollo Health and Lifestyle Limited, a wholly owned subsidiary of Apollo Hospitals Enterprise Limited, divested its entire shareholding in Apollo Specialty Hospitals Pvt Ltd and Apollo Fertility Centre Pvt Ltd to Kids Clinic India Limited.
- The divestment transaction was completed on 3 November 2026 with receipt of cash and equity stake consideration.
- Apollo Specialty Hospitals Pvt Ltd and Apollo Fertility Centre Pvt Ltd ceased to be subsidiaries following the divestment closure.
Key details
- The transaction's enterprise value was approximately ₹9,500 million, comprising ₹7,650 million cash consideration and a 9.9% equity stake in Kids Clinic India Limited valued at ₹1,850 million.
- Apollo Health and Lifestyle Limited now holds an effective 9.9% stake in Kids Clinic India Limited post-transaction.
- Transactions were approved by the Board in May 2026 and completed in November 2026.
Management commentary
- Dr. Madhu Sasidhar will cease to hold his position as President & CEO - Hospitals Division effective 14 November 2026 upon completion of his employment tenure.
- New senior management appointments include Dr. Ritu Garg as Chief Executive Officer for Multi Regions (North, Central, Western, and Eastern Regions).
Financial performance
- The Board approved unaudited standalone and consolidated financial results for the three and six months ended 30 September 2026.
- Total income reported for the quarter ended 30 September 2026 was ₹30,143 million with profit after tax of ₹4,757 million.
- Earnings per share for the quarter ended 30 September 2026 stood at ₹30.08 basic and ₹30.06 diluted.
Regulatory and governance context
- Financial results were reviewed by the company's statutory auditors and filed in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The changes in senior management personnel comply with SEBI Listing Regulations and related circulars.
Highlights
- Divestment closed on 3 November 2026 with Kids Clinic India Limited.
- Enterprise value of the deal approximately ₹9,500 million.
- Apollo Health and Lifestyle Limited received ₹7,650 million in cash and a 9.9% equity stake in Kids Clinic India valued at ₹1,850 million.
- Apollo Specialty Hospitals Pvt Ltd and Apollo Fertility Centre Pvt Ltd are no longer subsidiaries of Apollo Health and Lifestyle Limited.
- Dr. Madhu Sasidhar will cease to be President & CEO - Hospitals Division effective 14 November 2026.
- New senior management appointments made including Dr. Ritu Garg as CEO for Multi Regions.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- SEBI Master Circular
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Tube Investments of India Posts Rs. 188.16 Crore Net Profit in Q2 FY 2026-27, Approves Rs. 83 Crore Project to Expand CRSS Capacity
Tube Investments of India Limited released its unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026, reporting a net profit after tax of Rs. 188.16 crore for the quarter. Additionally, the company’s Board approved a capital expenditure of up to Rs. 83 crore to expand capacity in its Cold Rolled Steel Strips manufacturing at Avadi, targeting FY 2027-28 completion.
Read Full Story
Authum Investment & Infrastructure Ltd Announces Unaudited Financial Results for Q2 and H1 Ending September 30, 2026
Authum Investment & Infrastructure Ltd has released its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in compliance with SEBI Listing Regulations.
Read Full Story
Radico Khaitan Limited's Registrar and Share Transfer Agent Shifts Corporate Office to New Hyderabad Location from December 1, 2026
Radico Khaitan Limited has notified investors that its Registrar and Share Transfer Agent, KFin Technologies Limited, will relocate its corporate office in Hyderabad effective December 1, 2026, to a new address within Serilingampally Mandal, Ranga Reddy district.
Read Full Story
